Schönthal, A.H.; Swenson, S.; Minea, R.O.; Kim, H.N.; Cho, H.; Mohseni, N.; Kim, Y.-M.; Chen, T.C.
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia. Cancers 2021, 13, 3385.
https://doi.org/10.3390/cancers13143385
AMA Style
Schönthal AH, Swenson S, Minea RO, Kim HN, Cho H, Mohseni N, Kim Y-M, Chen TC.
Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia. Cancers. 2021; 13(14):3385.
https://doi.org/10.3390/cancers13143385
Chicago/Turabian Style
Schönthal, Axel H., Steve Swenson, Radu O. Minea, Hye Na Kim, Heeyeon Cho, Nazleen Mohseni, Yong-Mi Kim, and Thomas C. Chen.
2021. "Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia" Cancers 13, no. 14: 3385.
https://doi.org/10.3390/cancers13143385
APA Style
Schönthal, A. H., Swenson, S., Minea, R. O., Kim, H. N., Cho, H., Mohseni, N., Kim, Y.-M., & Chen, T. C.
(2021). Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia. Cancers, 13(14), 3385.
https://doi.org/10.3390/cancers13143385